Dr. Magdy F. Tawadrous, MD

Dr. Tawadrous practices at San Francisco Medical Center in San Francisco, California, part of Kaiser Permanente.

Dr. Tawadrous' NPI, 1407934029, was assigned on November 1, 2006. Dr. Tawadrous graduated from New York University School of Medicine in 1994. Dr. Tawadrous holds California license A79503.

Dr. Tawadrous' primary practice is San Francisco Medical Center, at 2425 Geary Blvd, San Francisco, CA 94115 in San Francisco County. The practice phone is (415) 833-2646.

Dr. Tawadrous' primary practice is San Francisco Medical Center in San Francisco, California, part of Kaiser Permanente. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Tawadrous to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tawadrous practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Tawadrous' primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Tawadrous is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Tawadrous' licenses on file in 2 states: California and Colorado.

Dmand AI lists angioplasty among the conditions Dr. Tawadrous treats.

CMS data shows 14 Medicare services from Dr. Tawadrous across 1 procedure code in 2024, for 22 Medicare patients. Medicare paid $93 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 22 Medicare patients who saw Dr. Tawadrous in 2024. 68% of them have high blood pressure, and 50% have high cholesterol. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tawadrous' median patient age at 63, with 53% women.

In 2024, Dr. Tawadrous wrote 319 Medicare Part D claims for 62 patients. 87% of them were for generic drugs. CMS names the drug for 218 of them, across 7 drugs with 11 or more claims each, at $13,894 in total drug cost. In 2023, CMS named 182 claims across 8 drugs.

Dr. Tawadrous accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Tawadrous in 2014. Dr. Tawadrous' most frequent co-authors are Alan S. Go, MD, James J. Jang, MD and Ashok Krishnaswami, MD.

CMS Open Payments shows 11 general payments to Dr. Tawadrous from 7 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $203.

Dmand AI lists 1 award for Dr. Tawadrous, most recently CMS Stage 1 2012 in 2011.

Dr. Tawadrous graduated from New York University School of Medicine in 1994.

Dr. Tawadrous is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.